Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

19991,094 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 354, Issue 9179, pp. 635-639

Field-Weighted Citation Impact: 22.19